Reporter brief
A Randomized Placebo-controlled Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Study. Extension Protocol
What happened
Trial registry update: ACTIVE_NOT_RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This is a protocol description rather than a results report; no efficacy or safety data are presented. Sample size and actual effect sizes are not reported, preventing assessment of statistical power or clinical significance. The study design and outcomes are stated as planned objectives rather than demonstrated findings.
Study design and sample
Other; Human.
Not recorded.
- Design
- Other
- Sample
- —
- Journal
- Haukeland University Hospital
- Published
- Sep 21, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Nicotinamide riboside timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.